Veru inc. (VERU)
CashFlow / Yearly
Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09
OPERATING ACTIVITIES
Net loss

-12,017

-23,938

-6,612

344

4,346

2,433

14,342

15,299

5,399

6,737

6,535

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

162

176

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

333

422

494

589

556

461

464

-

268

Amortization expense

309

275

147

-

-

-

-

-

-

-

-

Noncash interest expense

-4,706

-2,950

-

-

-

-

-

-

-

-

-418

Interest added to certificate of deposit

-

-

-

-

-

-

-

0

3

2

2

Depreciation and amortization

-

-

-

-

-

-

-

-

-

466

-

Amortization of deferred gain on sale and leaseback of building

-

-

-

-

-

-

-

-

-

-657

-88

Amortization of deferred income from grant

-

-

-

-

-

-

-

-

24

24

24

Share-based compensation

1,906

1,638

756

499

489

858

727

842

796

471

-

Warrants issued

-

-

542

-

-

-

-

-

-

-

-

Share-based compensation

-

-

-

-

-

-

-

-

-

-

373

Deferred income taxes

-438

630

-2,255

2,054

1,925

1,012

-5,259

-4,893

-2,464

-2,538

-1,597

Loss on settlement of accounts receivable

-

3,986

-

-

0

38

3

42

6

-

-1

Provision for obsolete inventory

109

90

345

-8

173

37

-6

128

177

-2

68

Change in fair value of derivative liabilities

-1,199

893

-

-

-

-

-

-

-

-

-

Other

142

-2

73

-

-

-

-

-

-

-

-

Loss on disposal of fixed assets

-

-

-

-0

-3

-0

-0

-11

-

-8

-6

Changes in current assets and liabilities:
Increase in accounts receivable

1,351

-1,874

-7,277

4,524

11,144

619

-4,903

5,005

-2,149

-3,345

1,293

Decrease in income tax receivable

-

-

-

-18

21

-78

51

27

-28

-39

66

Increase in inventory

1,454

-375

479

738

-1,064

561

994

-439

9

989

88

Increase in prepaid expenses and other assets

704

65

77

77

-58

151

-93

332

10

-56

48

Increase (decrease) in accounts payable

-56

495

897

-376

-47

220

-871

573

490

-15

44

Decrease in unearned revenue

-187

-487

1,014

-

-

-

-

-

-

-

-

Decrease in accrued expenses and other current liabilities

2,190

1,346

-

-

-

-

-

-

-

-

-

(Decrease) increase in accrued expenses and other current liabilities

-

-

-981

669

1,108

-270

-1,652

2,817

-30

-2,902

1,660

Net cash provided by (used in) operating activities

-

-

-

-1,714

-1,548

3,665

11,793

10,356

-

-

-

Net cash used in operating activities

-5,485

-11,546

982

-

-

-

-

-

6,968

3,991

5,747

INVESTING ACTIVITIES
(Increase) decrease in restricted cash

-

-

-

-

-

-

-

-

-

-100

-106

Proceeds from redemption of certificate of deposit

-

-

-

-

-

-

-

64

-

-

-

Proceeds from disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

32

Aquisition of Aspen Park Pharmaceuticals

-

-

-43

-

-

-

-

-

-

-

-

Capital expenditures

108

50

133

6

135

97

302

718

46

51

1,643

Net cash used in investing activities

-

-

-

-6

-135

-97

-302

-654

-

-

-

Net cash used in investing activities

-108

-50

-90

-

-

-

-

-

-46

49

-1,504

FINANCING ACTIVITIES
Proceeds from sale of shares in public offering, net of fees

9,400

-

-

-

-

-

-

-

-

-

-

Installment payments on SWK credit agreement

-

-

-

-

-

-

-

13

12

29

39

Payment of costs related to public offering

-

77

-

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock warrants

-

-

-

-

-

-

-

13

-

725

289

Proceeds from sale of shares under common stock purchase agreement

3,600

3,000

-

-

-

-

-

-

-

-

1

Payment of debt issuance costs

-

266

-

-

-

-

-

-

-

-

-

Installment payments on SWK credit agreement

4,935

642

-

-

-

-

-

-

-

-

-

Proceeds from stock option exercises

333

66

-

-

-

117

-

-

-

157

449

Payment of costs related to public offering

268

-

-

-

-

-

-

-

-

-

-

Proceeds from premium finance agreement

-

10,000

-

-

-

-

-

-

-

-

-

Purchases of common stock for treasury shares

-

-

-

-

0

737

395

289

33

349

3,831

Taxes paid in lieu of shares

-

-

-

-

-

-

-

2,177

-

313

-

Dividends paid on preferred stock

-

-

-

-

-

-

-

-

-

-

-104

Dividends paid on common stock

-

-

-

-

5

6,074

7,468

6,192

5,545

4,124

-

Net cash used in financing activities

-

-

-

-

-6

-6,694

-7,863

-8,660

-

-

-

Net cash provided by financing activities

8,129

12,078

-

-

-

-

-

-

-5,591

-3,932

-3,235

Net (decrease) increase in cash

2,535

481

-

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash

-

-

-

-

-

-

-

-

-

-

-119

Net increase in cash

-

-

892

-1,720

-1,690

-3,126

3,626

1,041

1,330

108

888

Issuance of common stock in connection with the APP Acquisition

-

-

1,826

-

-

-

-

-

-

-

-

Issuance of Series 4 Preferred Stock in connection with the APP Acquisition

-

-

17,981

-

-

-

-

-

-

-

-

Cash paid for income taxes

303

222

-

-

-

-

-

-

-

-

133

Cash paid for income taxes

-

-

230

352

294

773

345

926

57

111

-

Shares issued in connection with common stock purchase agreement

-

347

-

-

-

-

-

-

-

-

-

Amortization of deferred costs related to common stock purchase agreement

101

84

-

-

-

-

-

-

-

-

-

Reduction of accrued expense upon issuance of shares

-

-

-

-

-

-

-

174

221

92

72

Reduction of accrued expense upon issuance of shares

-

-

22

19

255

311

200

-

-

-

-

Increase in other assets from accounts payable and accrued expenses

-

190

-

2

-

-

-

124

-

-

86

Acquisition of equipment, furniture, and fixtures through capital lease

43

-

-

-

-

-

-

-

-

-

45